The Cadherin Cytoplasmic Domain Is Unstructured in the Absence of beta -Catenin

A POSSIBLE MECHANISM FOR REGULATING CADHERIN TURNOVER*

Andrew H. HuberDagger §, Daniel B. Stewart§, Douglas V. Laurents||, W. James Nelson§, and William I. WeisDagger §**

From the Departments of Dagger  Structural Biology, § Molecular and Cellular Physiology, and || Biochemistry, Stanford University School of Medicine, Stanford, California 94305

Received for publication, November 15, 2000, and in revised form, December 5, 2000



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cadherins are single pass transmembrane proteins that mediate Ca2+-dependent homophilic cell-cell adhesion by linking the cytoskeletons of adjacent cells. In adherens junctions, the cytoplasmic domain of cadherins bind to beta -catenin, which in turn binds to the actin-associated protein alpha -catenin. The physical properties of the E-cadherin cytoplasmic domain and its interactions with beta -catenin have been investigated. Proteolytic sensitivity, tryptophan fluorescence, circular dichroism, and 1H NMR measurements indicate that murine E-cadherin cytoplasmic domain is unstructured. Upon binding to beta -catenin, the domain becomes resistant to proteolysis, suggesting that it structures upon binding. Cadherin-beta -catenin complex stability is modestly dependent on ionic strength, indicating that, contrary to previous proposals, the interaction is not dominated by electrostatics. Comparison of 18 cadherin sequences indicates that their cytoplasmic domains are unlikely to be structured in isolation. This analysis also reveals the presence of PEST sequences, motifs associated with ubiquitin/proteosome degradation, that overlap the previously identified beta -catenin-binding site. It is proposed that binding of cadherins to beta -catenin prevents recognition of degradation signals that are exposed in the unstructured cadherin cytoplasmic domain, favoring a cell surface population of catenin-bound cadherins capable of participating in cell adhesion.



    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The formation and maintenance of solid tissues depends upon specific and regulated intercellular adhesion (1). Cadherins are single pass transmembrane adhesion proteins that link the cytoskeletons of adjacent cells in two kinds of intercellular junctions: the adherens junction and the desmosome. These structures play a critical role in tissue development, including cell segregation, condensation, polarization, and differentiation. Cadherin-mediated linkage of cytoskeletal networks imparts resistance to mechanical stress and enables concerted motions required by morphogenic processes. Defects in cadherin-mediated adhesion are associated with several characteristics of malignant transformation, such as dedifferentiation, high mobility, and invasive growth (2, 3).

Adherens junctions are sites of cell-cell contact that link the actin cytoskeletons of adjacent cells (4). Cadherin extracellular domains on opposing membranes mediate specific Ca2+- dependent, homotypic interactions. The cytoplasmic domains bind to beta -catenin, which in turn binds to the actin-associated protein alpha -catenin (4, 5). An analogous adhesion system exists in Drosophila, with armadillo and DE-cadherin the orthologues of beta -catenin and E-cadherin, respectively (6). Deletion mutagenesis studies have mapped the regions of E-cadherin and beta -catenin required for association. The C-terminal 72 residues of E-cadherin are necessary and sufficient for beta -catenin binding (7), and a 30-amino acid stretch within this region has been proposed to be the "core" beta -catenin binding sequence (8).

The primary structure of beta -catenin consists of an N-terminal region of 140 amino acids, followed by a 524-residue domain that contains 12 repeats of 42 amino acids known as armadillo (arm) repeats (9) and a 119-residue C-terminal tail. The arm repeat domain is required for association with cadherins (10, 11). The three-dimensional structure of the arm repeat domain showed that each arm repeat comprises three helices, with the repeats packing to form a superhelix of helices (12). The superhelix features a shallow groove with a positively charged surface potential. The core beta -catenin-binding region of E-cadherin, which has a calculated pI of 3.3, was proposed to bind within the positively charged groove presented by the beta -catenin armadillo domain (12).

Several mechanisms appear to modulate cadherin-based adhesion. Cadherins associate with beta -catenin shortly after biosynthesis, while still in the endoplasmic reticulum, and the two proteins move together to the cell surface, where they associate with alpha -catenin (13). Failure of cadherins to associate with beta -catenin leads to retention in the endoplasmic reticulum and degradation of cadherin (14). Adherens junction formation is also affected by phosphorylation (15, 16). For example, phosphorylation of serines in the the cadherin cytoplasmic tail by casein kinase II and glycogen synthase kinase-3beta kinases increases the affinity of cadherin for beta -catenin (16). Moreover, adherens junctions are enriched in protein-tyrosine kinases and phosphatases, some of which bind the cadherin-catenin complex directly (17-20). Tyrosine kinases target several adherens junction components that could modulate junctional stability, including beta -catenin (21) and the arm repeat protein p120ctn (22-24), which binds the cadherin cytoplasmic domain at a site distinct from beta -catenin (25, 26).

beta -Catenin also plays a central role in the Wnt/Wg growth factor signaling pathway that controls cell fate determination during embryogenesis (reviewed in Ref. 27). In this role beta -catenin acts as a transcriptional coactivator when bound to members of the lymphoid enhancer factor/T-cell factor (Lef/Tcf) transcription factor family (28, 29). Wnt signaling activates transcription by blocking or slowing the normally rapid turnover of beta -catenin, thereby elevating cytosolic levels of beta -catenin and promoting formation of an active beta -catenin-transcription factor complex (27). The cytosolic concentration of beta -catenin is normally maintained below the signaling threshold by a multi-protein complex that targets beta -catenin for ubiquitination and proteasomal degradation. This protein complex contains APC, the product of the adenomatous polyposis coli gene, the serine/threonine kinase GSK3beta , and Axin. The beta -catenin binding sequences in LEF-1 and APC are largely electronegative, and recent mutagenesis studies have indicated that they bind within the positively charged groove formed by the armadillo repeat region of beta -catenin (30). It is known that cadherin, APC, and LEF-1 compete for binding to the arm repeat domain of beta -catenin (11, 30), and it is likely that all three ligands bind to overlapping portions of the positively charged groove. Thus, depending on which ligand is bound, beta -catenin can have one of several distinct fates: adhesion complex component, transcriptional coactivator, or substrate for proteasomal degradation.

As a first step toward understanding the cadherin-beta -catenin interaction, we have used a variety of biophysical and biochemical techniques to characterize the cadherin cytoplasmic tail in the absence and presence of beta -catenin. Our analysis shows that the cadherin cytoplasmic tail is unstructured in isolation but appears to become structured upon binding to beta -catenin. Comparison of a variety of cadherin sequences reveals the presence of sequence motifs associated with proteosomal degradation. It is proposed that these properties are associated with the regulation of cadherin turnover and cellular adhesiveness.


    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protein Expression and Purification-- Murine beta -catenin and the cytoplasmic domain of murine E-cadherin (Ecyto, Arg580-Asp728)1 and Drosophila DE-cadherin (DEcyto, Gln1350-Ile1507) were expressed in Escherichia coli as C-terminal fusions to glutathione S-transferase (GST). Expression constructs were designed to leave a minimal number of additional residues (Gly-Ser-Pro for beta -catenin and Gly-Ser for the cadherins) at the N termini after cleavage of the GST fusion. No additional residues were added to the C termini. The bacterially expressed, recombinant cadherin cytoplasmic domains are designated rEcyto or rDEcyto.

beta -Catenin cDNA in pBluescript SKII+ (31) was digested with NdeI, and the resulting overhangs were filled with DNA polymerase I large (Klenow) fragment. Further digestion with SalI yielded the desired insert, which was ligated into SmaI-SalI-digested pGEX-KG (32). The sequence encoding the DE-cadherin cytoplasmic domain was amplified by polymerase chain reaction from a Drosophila head lambda ZAP® II cDNA library (Stratagene, La Jolla, CA) using primers 5'-GCGCCCGGATCCCAGAAGAAGCAGAAGAAT-3' and 5'-GCGCCCGATTTCTTTAGATGCGCCAGCCCTGGTC-3'. The resulting fragment was digested with EcoRI and BamHI and ligated into EcoRI-BamHI-digested pGEX-KG. The identity of the polymerase chain reaction product was verified by DNA sequencing and its ability to specifically bind armadillo and beta -catenin (data not shown). The GST-E-cadherin cytoplasmic domain fusion construct has already been described (33).

Transformed cells were grown in Super Broth, induced with 0.2 mM isopropyl-1-thio-beta -D-galactopyranoside and harvested by centrifugation 3 h after induction, and the cell paste was stored at -70 °C. Thawed cell paste was treated with protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 2 mg/ml aprotinin, and 4 mg/ml pepstatin-A) and deoxyribonuclease I, and the cells were lysed in a French pressure cell. Fusion proteins were batch affinity purified from lysates with glutathione-agarose beads (Sigma). GST-beta -catenin fusion protein was obtained by eluting the protein with a buffer containing 50 mM reduced glutathione. E- and DE-cadherin cytoplasmic domains and beta -catenin were obtained by cleaving the glutathione-agarose-bound fusion proteins with bovine thrombin (Sigma). Thrombin can cleave beta -catenin internally at Arg90 or Arg95. Thus, digestion of the GST-beta -catenin fusion yields full-length beta -catenin and two other major species. These fragments, which differ only at their N termini, copurify and are collectively named beta 76. Anion exchange and size exclusion chromatography were used to purify all protein products to near homogeneity.

Cadherin-beta -Catenin Stoichiometry Experiments-- Mixtures of rEcyto or rDEcyto and various beta -catenin constructs were incubated for more than 1 h at 4 °C and injected onto an Amersham Pharmacia Biotech HR 10/30 Superdex 200 size exclusion column equilibrated with 50 mM Tris-HCl, pH 8, 200 mM NaCl, 20 mM EDTA, and 1 mM DTT.

Endogenous versus Recombinant E-Cadherin-beta -Catenin Binding Studies-- MDCK cells (type II J) were maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum. Rabbit polyclonal antibody for the E-cadherin cytoplasmic domain was described previously (33). Mouse monoclonal antibodies for E-cadherin and beta -catenin were purchased from Transduction Laboratories. Polyclonal anti-E-cadherin and preimmune sera were covalently coupled to protein A-Sepharose. In each case, a ratio of 10 ml of serum to 75 ml of a 50% slurry of protein A-Sepharose was incubated for 12 h at 4 °C. The Sepharose was washed with 0.2 M borate, pH 9.0, and the antibodies were cross-linked to the protein A with dimethylpimelimidate (Pierce).

Cell extracts were prepared by washing 2 × 107 plated MDCK cells with ice-cold Tris-saline (20 mM Tris-HCl, pH 7.5, 154 mM NaCl) and scraping the cells in 2 ml of DTEB (0.5% Nonidet P-40, 50 mM Tris-HCl, pH 8.0, 100 mM NaCl) supplemented with protease and phosphatase inhibitors (0.1 mM Na3VO4, 50 mM NaF, 1 mM Pefabloc (Roche Molecular Biochemicals), and 10 mg/ml each of leupeptin, aprotinin, pepstatin-A, chymostatin, and antipain). Insoluble material was removed with a 10-min incubation on ice followed by centrifugation at 20,800 × g for 15 min. The resulting supernatant was "precleared" by incubating it with immobilized preimmune serum for 45 min at 4 °C, centrifuging it for an additional 5 min at 20,800 × g, and taking the new supernatant.

Precleared extract supernatant was incubated for 2 h at 4 °C with Sepharose-immobilized polyclonal E-cadherin antibody. Postincubation Sepharose was washed once with DTEB and twice with NaCl-supplemented DTEB. All washes were for 10 min at 4 °C and 10 different NaCl concentrations were used. Sepharose beads were resuspended in DTEB, centrifuged through a 1 M sucrose pad, washed with additional DTEB, and boiled for 5 min in SDS sample buffer. After separation on 6.5% SDS-PAGE gels, immunoprecipitated proteins were transferred to Immobilon-P polyvinylidene fluoride membrane (Millipore Corp.) and detected with murine monoclonal primary antibodies specific for E-cadherin and beta -catenin and 0.1 mCi/ml 125I-labeled goat anti-mouse secondary antibody (ICN Pharmaceuticals, Irvine, CA). Immunoblots were exposed to x-ray film (X-Omat AR; Eastman Kodak Co.) and quantified using a Molecular Dynamics Storm 820 PhosphorImager system.

To compare the behavior of recombinant beta -catenin-E-cadherin complexes with that of endogenous complex, 1:1 stoichiometric mixtures of the recombinant proteins were incubated on ice for 16 h and mock precleared as described above. Immunoprecipitations and washes were carried out as described above. Immunoprecipitates were separated on 12% SDS-PAGE gels and processed for immunoblotting and quantitation as described above.

Tryptophan Fluorescence and Fluorescence Anisotropy-- Tryptophan fluorescence emission and anisotropy experiments utilized an SLM 8000 C spectrofluorometer, featuring a T-format optical pathway and double and single grating excitation and emission monochromators, respectively. Data were taken at room temperature from continuously stirred samples. A 290 nm (8 nm bandpass) excitation wavelength was used for all experiments. Fluorescence emission spectra were recorded from 300 to 420 nm using a 4-nm emission bandpass and a 2.0-nm wavelength increment with a 1-s integration period. Tryptophan (12 mM), beta 76 (1 mM), and E- and DE-cadherin cytoplasmic tail (12 mM) samples were prepared using low ionic strength buffers (10-100 mM Tris-HCl or HEPES, pH 7.0-8.5, 20 mM NaCl) with 1 mM DTT or 10 mM beta -mercaptoethanol present for beta 76 and DE-cadherin. E-cadherin emission spectra were also measured under denaturing conditions (100 mM Tris-HCl, pH 7.0, 6 M guanidine HCl). Two-channel anisotropy data were collected using the "single point polarization" option and Schott WG-335 long pass filters instead of emission monochromators. Data were collected under native conditions (10 mM Tris-HCl, pH 8.5, 20 mM NaCl, 1 mM DTT) for E-cadherin (12 mM) and DE-cadherin (6, 3, or1.5 mM) cytoplasmic tails, beta 76 (2 mM), beta -catenin (3.5 mM), bovine serum albumin (BSA, 3 mM), and tryptophan (12 or 14 mM). Data were also collected under denaturing conditions (100 mM Tris-HCl, pH 7, 6 M guanidine HCl, and 1 mM DTT) for E- and DE- (6 mM) cadherin cytoplasmic tails, beta 76, BSA, and tryptophan.

Circular Dichroism-- Circular dichroism data were measured using an Aviv 60DS spectropolarimeter equipped with a Peltier temperature control unit (Hewlett-Packard 89100A). The spectropolarimeter was calibrated with (+)-10-camphorsulfonic acid and a 1-mm path length was used for all experiments. Spectra of E- and DE-cadherin cytoplasmic domains were measured in 10 mM phosphate, pH 7, at 0 °C. These spectra were measured in two parts, with 25 and 10 µM samples being used for 280-205- and 220-186-nm wavelength ranges, respectively. The two halves of each spectrum were scaled using the known sample concentrations.

NMR Measurements-- NMR spectra were acquired using a General Electric GN-Omega instrument operating at 500 MHz and a 680 µM sample of E-cadherin cytoplasmic domain in 5 mM Tris-HCl, pH 8, 10 mM NaCl, 0.35 mM trimethyl silyl propionate, and 50% D2O. Presaturation was used to suppress the H2O peak, and trimethyl silyl propionate was employed as the chemical shift standard. The sample was shimmed briefly before acquisition of one-dimensional 1H NMR spectra of 256 scans each (4096 real points; spectral width, 7000 Hz) at 50, 25, and 3 °C. NMR data were processed using Felix, version 2.30, from Biosym Technologies (San Diego, CA). The free induction decay was processed conservatively by Fourier transformation without premultiplication. Following phasing, the base lines were corrected by fitting to a zero order polynomial function.

Poly-L-glutamate versus E-Cadherin Binding Competition-- GST-beta -catenin fusion protein and glutathione-agarose were mixed for 45 min at room temperature in a binding buffer comprising 200 mM Tris-HCl, pH 8.5, 2 mM DTT, and either 100, 200, or 400 mM NaCl. Poly-L-glutamate (P1818 or P4636, with average molecular masses of roughly 1,000 and 11,000 Da, Sigma) was then added, and the mixtures were incubated an additional 45 min. E-cadherin was added, and after another 45-min incubation, the agarose beads were spun down, washed three times with the appropriate binding buffer, and boiled in reducing SDS-PAGE sample buffer. The sample supernatants were analyzed by SDS-PAGE. In each case, after the addition of E-cadherin, the incubation mixture was 3 µM in GST-beta -catenin, 3 µM in E-cadherin cytoplasmic domain, and 0, 3, 9, or 27 mM in poly-L-glutamate. Different E-cadherin and poly-L-glutamate stocks were made using the appropriate binding buffers.

Limited Proteolysis of Cadherin-beta -Catenin Complexes-- Approximately 25 µM recombinant E-cadherin cytoplasmic domain (rEcyto) alone or mixed in 1:1 stoichiometric amounts with either full-length beta -catenin or the armadillo repeat region (beta 59) (12) was subjected to limited proteolysis with subtilisin. A control mixture containing 25 µM rEcyto and 30 µM bovine serum albumin was also digested. Mixtures were incubated at 4 °C for 1 h and digested for 20 min at room temperature with subtilisin concentrations ranging from 0.08 to 1.3 µg/ml. Digestions were carried out in a buffered solution comprising 100 mM CHES, pH 9.2, 2 mM CaCl2, and 5 mM DTT. This pH is suboptimal for subtilisin but is required for beta 59 solubility. In separate experiments, rEcyto-beta -catenin complex was digested with endoproteinase Glu-C using concentrations ranging from 0.4 to 27 µg/ml; these reactions were carried out in 50-100 mM Tris-HCl, pH 8.5, 2 mM CaCl2, and 5 mM DTT. rDEcyto-beta -catenin complex was also digested with subtilisin as described for rEcyto. Subtilisin digestions were stopped by adding phenylmethylsulfonyl fluoride to a final concentration of 8 mM, and endoproteinase Glu-C digestions were stopped by boiling.

Sequence Analysis-- Cytoplasmic tail sequences from 18 different vertebrate subtypes of classical/type I and atypical/type II cadherins were analyzed. These sequences are mostly of human origin and represent 6 type I cadherins (E-cadherin, N-cadherin, P-cadherin, R-cadherin, M-cadherin, and Xenopus laevis EP-cadherin; GenBankTM accession numbers Z13009, M34064, X63629, L34059, D83542, and U04707, respectively) and 12 type II cadherins (cadherin-5, cadherin-6, cadherin-7, cadherin-8, cadherin-9, cadherin-10, cadherin-11, cadherin-12, cadherin-18, cadherin-19, cadherin-20, and Rattus norvegicus PB-cadherin; GenBankTM accession numbers X79981, D31784, AJ007611, L34060, AB035302, AF039747, L34056, L34057, U59325, AJ007607, AF217289, and D83348, respectively) as described in a recent phylogenetic analysis of the cadherin superfamily (34). The PEST-FIND program (35) was used with a sequence window of 10 as implemented at EMBnet Austria. Aliphatic and instability indices were calculated using the ProtParam tool at the ExPASy proteomics server. An "aspartic acid index," which compares the normalized change in total aspartic acid content relative to total glutamic acid content, is defined as 1.207 (%Asp/%Glu) where 1.207 is the ratio of the compositional percentage for Glu (numerator) and Asp as found in SWISS-PROT Release 38.0 and %Asp and %Glu represent the compositional percentages found in a given cadherin cytoplasmic tail.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Recombinant Cadherin Cytoplasmic Domains Are Not Folded in Isolation-- Fluorescence, circular dichroism, and proton NMR were used to characterize the folded state of recombinant E-cadherin and DE-cadherin cytoplasmic domains (rEcyto and rDEcyto respectively). Ecyto contains a single tryptophan that is located near the C terminus of the protein. DEcyto has two tryptophans that are near the N and C termini, the latter in a position distinct from the tryptophan in Ecyto. In a folded protein, the tryptophan indole ring is frequently buried within a hydrophobic core or is otherwise shielded from solvent, resulting in a blue shift of the fluorescence maximum relative to free tryptophan (36). The tryptophan emission maximum for beta 76, a thrombin-generated fragment of beta -catenin (see "Experimental Procedures"), is significantly blue-shifted relative to tryptophan alone, whereas the maxima for Ecyto and DEcyto are not (Table I). Thus, the single Ecyto tryptophan and two DEcyto tryptophans appear to be solvent exposed.


                              
View this table:
[in this window]
[in a new window]
 
Table I
Tryptophan fluorescence data
ND, not determined.

Folded and denatured proteins commonly display significantly different fluorescence anisotropy values because of the loss of rotational freedom that occurs when a tryptophan indole ring is buried in a hydrophobic core. beta -Catenin and BSA yield anisotropy values of ~0.085 when folded and ~0.035 when denatured with 6 M guanidine HCl (Table I). In contrast, recombinant E- and DE-cadherin cytoplasmic domains have anisotropy values comparable with those observed with denatured proteins, and these values do not change significantly when the cadherins are subjected to denaturants (Table I).

The fluoresence anisotropy data suggest that the Ecyto and DEcyto domains are unfolded under native conditions. However, regions of a folded protein that lack structure, such as large loops or unstructured N and C termini, might give similar results. CD spectroscopy was therefore used to probe for the presence regular protein secondary structure. The spectra measured for rEcyto and rDEcyto at 0 °C are essentially identical and feature a single minimum in mean residue ellipticity at ~202 nm (Fig. 1). This spectrum indicates a lack of secondary structure, which would be expected of an unstructured polypeptide (37, 38).



View larger version (15K):
[in this window]
[in a new window]
 
Fig. 1.   Circular dichroism spectra for recombinant E- and DE-cadherin cytoplasmic domains. Both samples were prepared using a 10 mM phosphate pH 7 buffer and measured at 0 °C. Spectra were converted to mean residue ellipticity.

To eliminate the possibility that the cytoplasmic tail has a defined conformation without regular secondary structure, one-dimensional 1H NMR spectra were measured at 3, 25, and 50 °C (Fig. 2). At 50 °C, peaks with the chemical shift values of random coil peptides (39) are observed at 0.95 ppm (delta  and gamma  protons of Ile, Leu, and Val), 2.10 ppm (epsilon  protons of Met), and 6.81 ppm (Tyr ring protons). Resolved peak doublets at 7.47 and 7.58 ppm are consistent with exposed C7 and C4 Trp protons, as one would find in an unfolded protein. A broad, very low shoulder between 8 and 9 ppm suggests that amide protons are unprotected and in rapid exchange with solvent protons and deuterons. These data indicate that rEcyto is unfolded at 50 °C. Spectra recorded at 25 and 3 °C are similar to that of the 50 °C spectrum (Fig. 2). However, amide proton peaks appear at 25 °C and become more prominent at 3 °C, with a single small alkyl peak becoming resolved at 0.70 ppm. The appearance of amide proton peaks may result from secondary structure formation, or from a lower rate of solvent exchange resulting from the decreased temperature. Because the amide resonances lack the chemical shift dispersion that accompanies secondary structure formation, the latter explanation is more likely. Thus, rEcyto appears to be largely unstructured at 50, 25, and 3 °C.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 2.   Proton NMR spectra for the recombinant E-cadherin cytoplasmic domain taken at 50, 25, and 3 °C. Spectra were measured with at 500 MHz using a 680 µM sample of cadherin cytoplasmic domain in 5 mM Tris-HCl, pH 8, 10 mM NaCl, 0.35 mM trimethyl silyl propionate, and 50% D2O. The temperature at which each spectrum was measured is indicated on the left.

Recombinant E-Cadherin Cytoplasmic Domain and Endogenous E-Cadherin Have Similar beta -Catenin Binding Properties-- The beta -catenin binding properties of rEcyto were compared with those of E-cadherin isolated from eukaryotic cells. Full-length beta -catenin, as well as fragments lacking the first ~90 amino acids (beta 76; see "Experimental Procedures") or comprising the arm repeats (beta 59) (12) were used in these experiments. Size exclusion chromatography (Table II) and native gel electrophoresis (data not shown) were used to separate mixtures comprising 2:1, 1.5:1, 1:1, 1:1.5, and 1:2 molar ratios of beta 76 and rEcyto. Similar experiments were carried out with rEcyto-beta -catenin, rDEcyto-beta catenin, and rEcyto-beta 59 complexes (data not shown). All experimental results were consistent with the 1:1 stoichiometry previously derived using endogenous proteins (13, 40). To compare directly the stability of recombinant and endogenous E-cadherin-beta -catenin complex, we examined the sensitivity of each complex to salt washes, a common method of testing protein-protein interactions in cell extracts. Endogenous E-cadherin-beta -catenin complex was immunoprecipitated from MDCK cell extracts with polyclonal anti-E-cadherin antibodies attached to Sepharose beads. Recombinant beta -catenin-Ecyto complexes were prepared in parallel and immunoprecipitated using the same buffer conditions. After washing the immunoprecipitates, the beads were incubated with buffers containing increasing concentrations of NaCl. The amount of complex resistant to dissociation was assayed by Western blots of the post-wash bead-associated proteins with cadherin and beta -catenin-specific antibodies. The stability of the recombinant complex in NaCl was found to be similar to that observed with the endogenous proteins (Fig. 3). Although the two curves agree within experimental error, the recombinant complex was consistently slightly less stable than the endogenous complex. It is possible that the increased stability of the endogenous complex is the result of post-translational modifications, such as phosphorylation (16).


                              
View this table:
[in this window]
[in a new window]
 
Table II
beta -Catenin/E-cadherin complex stoichiometry as determined by size exclusion chromatography using purified recombinant proteins
beta 76, a fragment of beta -catenin extending from residue Arg90 or Arg95 to the C terminus, and recombinant E-cadherin cytoplasmic domain (rEcyto) were mixed at various ratios, incubated for more than 1 h at 4 °C, and injected onto an Amersham Pharmacia Biotech HR 10/30 Superdex 200 column. Peaks were integrated by photocopying the chart recorder trace, cutting out the peaks, and weighing them. The peak masses for one molar equivalent of beta 76 and Ecyto were determined in independent runs (data not shown).



View larger version (49K):
[in this window]
[in a new window]
 
Fig. 3.   The stability of recombinant and endogenous E-cadherin-beta -catenin complexes as a function of NaCl concentration. Recombinant (Rec and RECOMB) Ecyto-beta -catenin and endogenous E-cadherin-beta -catenin complexes from MDCK cell extracts were immunoprecipitated using an immobilized anti-E-cadherin antibody. Samples were washed with buffers containing different NaCl concentrations and boiled, and the proteins were separated by SDS-PAGE. beta -catenin and E-cadherin were detected by Western blotting with 125I-labeled antibody and quantitated using a phosphorimaging system. Each plotted data point is the mean beta -catenin-E-cadherin ratio from four experiments. The S.D. for each point is displayed as a bar. Cad, cadherin; beta -cat, beta -catenin.

Electrostatic Complementarity Is Not a Dominant Factor in E-Cadherin-beta -Catenin Complex Stability-- The positively charged groove presented by beta -catenin and the overall negative charge of the beta -catenin-binding regions of E-cadherin, LEF-1, and APC suggests that electrostatic complementarity has a major role in the interaction of these proteins with beta -catenin. As a simple test of this hypothesis, we examined the salt dependence of the interaction. As described above (Fig. 3), increasing NaCl concentrations reduce the stability of the E-cadherin-beta -catenin complex. However, roughly 50% of the cadherin-beta -catenin complex remains in NaCl concentrations as high as 2.5 M, suggesting that electrostatics make only a modest contribution to complex stability. To further gauge the contribution of electrostatics in complex formation, we tested whether the poly-L-glutamate polyanion P1818 (~1000 Da; average length, 10 residues) could act as competitive inhibitor of rEcyto-beta -catenin complex formation. P1818 is a weak competitor of rEcyto for beta -catenin binding when present at a 1000-fold molar excess and an effective competitor when present at a 9000-fold molar excess (Fig. 4). Increasing the ionic strength of the incubation mixture by adding NaCl significantly diminishes P1818 competitive inhibition (Fig. 4). The observed inhibition of cadherin binding by P1818 and its salt dependence are consistent with a nonspecific and largely electrostatic association of poly-glutamate with beta -catenin. Collectively, these observations suggest that although electrostatic complementarity plays a role in cadherin-beta -catenin complex formation, it is not a dominant factor in the stability of the complex.



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   E-cadherin-beta -catenin complex formation in the presence of poly-L-glutamate. GST-beta -catenin fusion protein was bound to glutathione agarose and incubated with an equimolar amount of Ecyto in the presence of various amounts of poly-L-glutamate. Postincubation beads were washed with buffer, and the bound proteins were analyzed by SDS-PAGE. The experiment was carried out using three different incubation buffers that differed only in NaCl concentration. The molar excess of poly-L-glutamate and the concentration of NaCl in the incubation buffer are shown above the lanes. The positions of molecular mass standards are marked with arrows on the left side of the figure and labeled in kilodaltons. The positions of GST-beta -catenin and Ecyto bands are labeled on the right.

beta -Catenin Binding Protects Ecyto from Proteolysis-- The cadherin cytoplasmic domain is unstructured in isolation, but it could become structured or fold upon binding beta -catenin. Compact globular domains typically exhibit some resistance to proteolytic degradation, so limited proteolysis is one means of ascertaining structural stability. The relatively nonspecific protease subtilisin and the acid-specific protease endoproteinase Glu-C (V8 protease) both readily digest rEcyto. However, in the presence of beta -catenin, what appears to be full-length rEcyto remains at subtilisin (Fig. 5) and endoproteinase Glu-C (data not shown) concentrations that completely degrade rEcyto alone (Fig. 5, lanes 5 and 7 or lanes 12 and 14). Similar protection results were obtained with the DEcyto-beta -catenin complex and subtilisin (data not shown). beta 59, the armadillo repeat domain of beta -catenin (12), is thought to contain the entire cadherin-binding site. This fragment also protects rEcyto from degradation but does so less effectively than full-length beta -catenin (Fig. 5, lanes 7 and 9 or lanes 14 and 16). BSA-rEcyto mixtures were used to test whether the protection afforded by full-length beta -catenin was simply due to the addition of an alternative substrate for subtilisin. The amount of BSA used in the digests was chosen to provide the same number of peptide bonds as full-length beta -catenin. Adding BSA protects Ecyto somewhat (Fig. 5, lanes 5, 10, and 11), but the protection is substantially weaker than that afforded by beta -catenin and slightly weaker than that provided by beta 59 (Fig. 5, lanes 9 and 11 or lanes 16 and 18).



View larger version (25K):
[in this window]
[in a new window]
 
Fig. 5.   Limited proteolysis of Ecyto-beta -catenin and Ecyto-beta 59 complexes. The E-cadherin cytoplasmic domain alone or in the presence of beta -catenin, beta 59, or BSA was digested with subtilisin for 20 min, the digest was stopped with phenylmethylsulfonyl fluoride, and the products were analyzed by SDS-PAGE. The concentration of subtilisin in each digest is indicated above the lanes, as are the proteins present in the digest. The positions of molecular mass markers are indicated with arrows on the left and labeled in kilodaltons. Every fifth lane is numbered at the bottom for ease of reference.

Instability Is Reflected in the Sequences of the Cadherin Cytoplasmic Tails-- A protein that is normally unstructured in solution might be expected to have a higher than average number of charged/polar residues and a lower than average number of hydrophobic residues. Analysis of 18 type I and type II cadherins shows that they contain on average 41% more charged residues (Arg, Asp, Glu, and Lys) and 29% fewer aliphatic residues (Ile, Leu, Met, Phe, and Val) relative to the average amino acid composition of the proteins in the SWISS-PROT data base (Release 38). Given that the average calculated pI for the cytoplasmic tails is 4.4, it is not surprising that most of the increase in charge is from a higher than usual number of aspartic and glutamic acid residues. In most cases the compositional increase in Asp far outweighs that of Glu, as reflected in the "Asp index," which we define as the normalized change in total apartic acid content relative to total glutamic acid content (Fig. 6). It is interesting to speculate that this bias is related to the lack of tertiary structure seen in the domain; the side chain of Asp is less hydrophobic than that of Glu, making it less likely to form favorable packing interactions with other residues. The aliphatic index (AI), a measure of hydrophobicity and thermostability (41), was also calculated from these sequences. This is a compositional index based upon the sum of the mole percentages of Ala, Val, Ile, and Leu weighted by the relative side chain volumes. Proteins from thermophilic bacteria have been found to have a significantly higher AI value (mean of 92.6, S.D. of 10.6) than proteins from mesophilic organisms (mean of 78.8, S.D. of 14.5). Thus, a higher AI value is correlated with higher thermostability. The sequences from the cadherin cytoplasmic tails have AI values (mean of 64.4, S.D. of 4.2) significantly below that found for mesophilic proteins.



View larger version (48K):
[in this window]
[in a new window]
 
Fig. 6.   Sequence alignment and analysis of cadherin cytoplasmic domains. The cytoplasmic domains of six type I and twelve type II cadherins were analyzed with all except those marked as originating from X. laevis (Xl) or R. norvegicus (Rn) being of human origin. The alignment includes only the C-terminal PEST region of the cadherins, with the residue numbers for the mature cadherin-1 protein (CAD 1) shown above. PEST sequences are shaded, and a box has been placed around the highly conserved (Leu-Ser-Ser-Leu) motif. The PEST-FIND score (PEST) for the highlighted sequences, as well as the instability (II), aliphatic (AI), and aspartic acid (AAI) indices for the entire cytoplasmic domain are shown to the right of each sequence. The minimal beta -catenin-binding region is indicated at the bottom. A cluster of phosphorylated serines identified in cadherin-1 is shown with asterisks.

Cadherins appear to be targeted for degradation when not bound to beta -catenin (14). Because the PEST sequence motif is correlated with rapid protein turnover in vivo (35), we used the PEST-FIND program to identify potential PEST sequences within the cadherin cytoplasmic domains. PEST sequences contain Pro, Glu or Asp, and Ser or Thr and are flanked by but do not contain basic residues (His, Arg, and Lys). PEST sequences with PEST-FIND scores greater than +5 are considered the best candidates for being degradation signals, but many proteins containing sequences with lower PEST scores are known to be degraded (35). Of the 18 cadherin cytoplasmic domains analyzed, 15 have positive scoring PEST sequences that contain or overlap the serine-rich, minimal beta -catenin-binding region in the C-terminal half of the domain; 12 of these sequences score greater than +3, and 4 have values greater than +5 (Fig. 6). This minimal beta -catenin-binding region of cadherin also has two features frequently found in synthetic signals that target proteins to the ubiquitin-proteasome system in Saccharomyces cerevisiae: a high content of serine and threonine residues and a frequently recurring sequence motif, (bulky hydrophobic)- (S or T)-(S or T)-(bulky hydrophobic) (42). The sequence motif Leu-Ser-Ser-Leu is very highly conserved within the cadherin cytoplasmic tail and is located within the minimal beta -catenin-binding region (Fig. 6). It should also be noted that five of the six type I (E-, N-, R, P-, and EP-cadherins) and two of the twelve type II (cadherin-8 and cadherin-20) cadherins had positive scoring PEST sequences in the membrane-proximal, N-terminal half of the cytoplasmic domain. All of these membrane-proximal type I cadherin PEST sequences scored greater than +3.5. This region harbors the p120ctn-binding site (25, 26).

We calculated the instability index (II), a measure that is based upon a correlation between the stability of a protein in vivo and the frequency of certain dipeptides in its sequence (43), for each of the 18 sequences analyzed above. Index values greater than 40 are indicative of metabolic instability, which is defined as an in vivo half-life of less than 5 h. The average cadherin cytoplasmic tail II value was 56.6 (Fig. 6), and only the cadherin-8 cytoplasmic tail was predicted to be stable.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cytoplasmic tail is the most highly conserved domain among type I cadherins (34). With a length of ~150 residues, it is easily large enough to be an independently folded structural unit. We expressed the E- and DE-cadherin cytoplasmic domains in E. coli and purified them to homogeneity. Tryptophan fluorescence, circular dichroism, and one-dimensional proton NMR studies all lead to the same surprising conclusion: rEcyto and rDEcyto are unfolded in solution. The recombinant domains appear to have the same biochemical properties as those of endogenous cadherins. They form 1:1 stoichiometric complexes with beta -catenin, and the stability of the rEcyto-beta -catenin complex as a function of salt concentration is comparable with that of endogenous E-cadherin-beta -catenin complex. In addition, rEcyto and rDEcyto can be concentrated to 40 and 20 mg/ml, respectively,2 without the aggregation that would occur with a "misfolded" protein. Thus, it is unlikely that the recombinant proteins are simply misfolded in bacteria, and it is highly probable that endogenous cadherin cytoplasmic domains are also unfolded.

beta -Catenin appears to protect full-length rEcyto from degradation under conditions that completely degrade rEcyto alone. The beta -catenin-binding site of E-cadherin is thought to lie within the C-terminal 72 residues of the 150-amino acid cytoplasmic tail, with the minimal binding site encompassing just 30 residues (8). Given the relatively short binding sequence and the unfolded state of Ecyto, proteolytic protection by sequestration of the entire domain seems unlikely. The simplest explanation is that Ecyto adopts a defined conformation upon binding to beta -catenin. We interpret the observed difference in protection provided by full-length beta -catenin and beta 59 as evidence that regions of beta -catenin outside the arm repeat domain interact with E-cadherin. A structuring of cadherin upon binding to beta -catenin may facilitate interactions between cadherins and other junctional components such as p120ctn.

The acidic nature of the beta -catenin-binding regions of cadherins, APC, and LEF/Tcf transcription factors led us to propose that these otherwise unrelated proteins bind as extended polypeptides in the electrostatically positive groove present in the arm repeat region of beta -catenin (12). Indirect support for the groove binding model comes from the observation that nuclear localization signal peptides bind in an extended conformation within the groove of the karyopherin alpha  arm repeat domain (44). Recent site-directed mutagenesis data have shown that APC and LEF-1 bind within the groove of beta -catenin (30). As cadherins compete with APC and LEF-1 for binding to beta -catenin (11, 30), it is likely that cadherin also interacts with this region. Although the groove appears to be the binding site for beta -catenin ligands, our results indicate that electrostatic complementarity is not a major contributor to the stability of the cadherin-beta -catenin complex. This is consistent with experimental and theoretical studies showing that the energetically favorable interactions between complementary charges do not always compensate for the unfavorable desolvation of the participating charged groups (45, 46). Although charged and polar interactions may not have a dominant role in complex stability, they are generally important for specificity, because the cost of desolvating polar groups upon burial in an interface must be offset by electrostatically complementary interactions. In addition, long range electrostatic interactions may be used to enhance rates of association, because they can provide attractive forces even during molecular rotation and realignment (47).

Electrostatic complementarity between beta -catenin and Ecyto may simply be a consequence of maintaining the cadherin cytoplasmic domain in an extended, unstructured state that can readily bind to beta -catenin. When unfolded, a typical globular protein has poor solubility properties and is prone to aggregation. Thus, it is not surprising that the cadherin cytoplasmic domains have compositions skewed toward charged amino acids at the expense of aliphatic residues. Such a composition is likely to favor an extended conformation, because charge-charge repulsion will reduce the likelihood of self-association. beta -Catenin may present an electrostatically positive surface to complement the acidic character required to maintain cadherin as an unstructured protein.

The lack of structure seen in the uncomplexed cadherin tail may be related to the turnover of cadherins. E-cadherin has a relatively short half-life (<5 h) in MDCK cells (48). beta -Catenin associates with E-cadherin shortly after cadherin synthesis (13), and mutants deficient for beta -catenin binding are retained within the endoplasmic reticulum and are rapidly degraded (14). We have shown here that the majority of cadherin cytoplasmic domains contain PEST sequence motifs. The PEST sequences may function as signals for the degradation of "catenin-free" or uncomplexed cadherins.

Some of the cadherin tail sequences have low PEST scores (Fig. 6), but other low scoring PEST sequences are known to be proteolytic degradation signals (35). Moreover, it has been shown that phosphorylation may activate a latent or low-scoring PEST sequence (35, 49-53). A well studied example is the degradation of Ikappa B proteins, inhibitors of the transcription factor NF-kappa B (54). The presence and phosphorylation of PEST sequences in Ikappa Bs is required for a rapid and constitutive turnover of free Ikappa Bs that may facilitate sustained NF-kappa B activity (55-58). Interestingly, a subclass of constitutively active Ras superfamily members binds to and possibly sequesters the PEST regions of free Ikappa B proteins, regulating their turnover (59). The E-cadherin PEST sequence is phosphorylated in a serine-rich region that is highly conserved among type I cadherins and is also present in type II cadherins (Fig. 6) (8), suggesting that phosphorylation can activate these degradation signals as well.

The PEST and beta -catenin-binding regions of cadherins overlap extensively, and phosphorylation of the serines in this region has been shown to increase the affinity of E-cadherin for beta -catenin (16). It is not known when or where in the cell cadherins are phosphorylated. Binding of cadherins to beta -catenin may prevent phosphorylation by sequestering the PEST serines from kinases. Those cadherin molecules that have already been phosphorylated will have increased affinity for beta -catenin. Upon beta -catenin binding, these activated PEST sequences would again be sequestered, this time from recognition by the degradation machinery. Either or both of these scenarios would lead to selective degradation of those cadherin molecules that fail to bind to beta -catenin.

Given that the cytoplasmic domains of cadherins are unstructured in the absence of beta -catenin, they are likely to be good substrates for kinases as well as the cellular protein degradation machinery. Functional adhesion requires cadherins to be linked to the cytoskeleton through beta - and alpha -catenins, so free cadherin molecules at the cell surface might act as competitive inhibitors of adhesion. Cytosolic levels of beta -catenin are tightly controlled to prevent inappropriate activation of Wnt-responsive genes. Increasing beta -catenin levels by induction of the Wnt pathway increases the formation of cadherin-catenin complex and cell-cell adhesion in some cell lines (60, 61). Likewise, the increased level of total beta -catenin following overexpression of cadherin in other cell lines likely reflects stabilization of beta -catenin molecules that would otherwise be turned over by the Wnt pathway (25, 62-64). These observations indicate that cadherin and beta -catenin turnover are coupled. Cadherins that are not associated with beta -catenin may be targeted for degradation by sequences in their unstructured cytoplasmic domains, reducing the population of catenin-free cadherins at the cell surface.


    ACKNOWLEDGEMENTS

We thank Y. Wang and S. Fridman for technical assistance, J. Ames and K. Ng for advice on fluorescence experiments, T. Schwarz for kindly providing the Drosophila head cDNA library, and K. Spink and S. Pokutta for discussions and comments on the manuscript.


    FOOTNOTES

* This work was supported by Grants GM56169 (to W. I. W.) and GM35227 (to W. J. N.) from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a Jane Coffin Childs Memorial Postdoctoral Fellowship.

** To whom correspondence should be addressed: Dept. of Structural Biology, Stanford University School of Medicine, 299 Campus Dr. West, Stanford, CA 94305. Tel.: 650-725-4623; Fax: 650-723-8464; E-mail: bill.weis@stanford.edu.

Published, JBC Papers in Press, December 19, 2000, DOI 10.1074/jbc.M010377200

2 A. H. Huber and W. I. Weis, unpublished observations.


    ABBREVIATIONS

The abbreviations used are: rEcyto, recombinant cytoplasmic domain of E-cadherin; rDEcyto, recombinant cytoplasmic domain of DE-cadherin; beta 76, thrombolytic fragment of beta -catenin; beta 59, armadillo repeat region of beta -catenin; GST, glutathione S-transferase; DTT, dithiothreitol; BSA, bovine serum albumin; CHES, 2-(cyclohexylamino)ethanesulfonic acid; MDCK, Madin-Darby canine kidney; AI, aliphatic index.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES


1. Gumbiner, B. M. (1996) Cell 84, 345-357[Medline] [Order article via Infotrieve]
2. Behrens, J., Mareel, M. M., Van Roy, F. M., and Birchmeier, W. (1989) J. Cell Biol. 108, 2435-2447[Abstract]
3. Vleminckx, K., Vakaet, L., Jr., Mareel, M., Fiers, W., and Van, R.oy, F. (1991) Cell 66, 107-119[Medline] [Order article via Infotrieve]
4. Yap, A. S., Brieher, W. M., and Gumbiner, B. M. (1997) Annu. Rev. Cell Dev. Biol. 13, 119-146[CrossRef][Medline] [Order article via Infotrieve]
5. Ozawa, M., Baribault, H., and Kemler, R. (1989) EMBO J. 8, 1711-1717[Abstract]
6. Oda, H., Uemura, T., Harada, Y., Iwai, Y., and Takeichi, M. (1994) Dev. Biol. 165, 716-726[CrossRef][Medline] [Order article via Infotrieve]
7. Ozawa, M., Ringwald, M., and Kemler, R. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4246-4250[Abstract]
8. Stappert, J., and Kemler, R. (1994) Cell Adhesion Commun. 2, 319-327[Medline] [Order article via Infotrieve]
9. Peifer, M., Berg, S., and Reynolds, A. B. (1994) Cell 76, 789-791[Medline] [Order article via Infotrieve]
10. Aberle, H., Butz, S., Stappert, J., Weissig, H., Kemler, R., and Hoschuetzky, H. (1994) J. Cell Sci. 107, 3655-3663[Abstract/Free Full Text]
11. Hülsken, J., Birchmeier, W., and Behrens, J. (1994) J. Cell Biol. 127, 2061-2069[Abstract]
12. Huber, A. H., Nelson, W. J., and Weis, W. I. (1997) Cell 90, 871-882[Medline] [Order article via Infotrieve]
13. Hinck, L., Nathke, I. S., Papkoff, J., and Nelson, W. J. (1994) J. Cell Biol. 125, 1327-1340[Abstract]
14. Chen, Y.-T., Stewart, D. B., and Nelson, W. J. (1999) J. Cell Biol. 144, 687-699[Abstract/Free Full Text]
15. Gumbiner, B. M. (2000) J. Cell Biol. 148, 399-403[Abstract/Free Full Text]
16. Lickert, H., Bauer, A., Kemler, R., and Stappert, J. (2000) J. Biol. Chem. 275, 5090-5095[Abstract/Free Full Text]
17. Hoschuetzky, H., Aberle, H., and Kemler, R. (1994) J. Cell Biol. 127, 1375-1380[Abstract]
18. Brady-Kalnay, S. M., Rimm, D. L., and Tonks, N. K. (1995) J. Cell Biol. 130, 977-986[Abstract]
19. Kypta, R. M., Su, H., and Reichardt, L. F. (1996) J. Cell Biol. 134, 1519-1529[Abstract]
20. Brady-Kalnay, S. M., Mourton, T., Nixon, J. P., Pietz, G. E., Kinch, M., Chen, H., Brackenbury, R., Rimm, D. L., Del Vecchio, R. L., and Tonks, N. K. (1998) J. Cell Biol. 141, 287-296[Abstract/Free Full Text]
21. Roura, S., Miravet, S., Piedra, J., García de Herreros, A., and Dunach, M. (1999) J. Biol. Chem. 274, 36734-36740[Abstract/Free Full Text]
22. Reynolds, A. B., Daniel, J., McCrea, P. D., Wheelock, M. J., Wu, J., and Zhang, Z. (1994) Mol. Cell. Biol. 14, 8333-8342[Abstract]
23. Shibamoto, S., Hayakawa, M., Takeuchi, K., Hori, T., Miyazawa, K., Kitamura, N., Johnson, K. R., Wheelock, M. J., Matsuyoshi, N., Takeichi, M., and Ito, F. (1995) J. Cell Biol. 128, 949-957[Abstract]
24. Staddon, J. M., Smales, C., Schulze, C., Esch, F. S., and Rubin, L. L. (1995) J. Cell Biol. 130, 369-381[Abstract]
25. Yap, A. S., Niessen, C. M., and Gumbiner, B. M. (1998) J. Cell Biol. 141, 779-789[Abstract/Free Full Text]
26. Ohkubo, T., and Ozawa, M. (1999) J. Biol. Chem. 274, 21409-21415[Abstract/Free Full Text]
27. Polakis, P. (2000) Genes Dev. 14, 1837-1851[Free Full Text]
28. Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996) Nature 382, 638-642[CrossRef][Medline] [Order article via Infotrieve]
29. van de Wetering, M., Cavallo, R., Booijes, D., van Beest, M., van Es, J., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M., and Clevers, H. (1997) Cell 88, 789-799[Medline] [Order article via Infotrieve]
30. von Kries, J. P., Winbeck, G., Ashbrand, C., Schwarz-Romond, T., Sochnikova, N., Dell'Oro, A., Behrens, J., and Birchmeier, W. (2000) Nature Struct. Biol. 7, 800-807[CrossRef][Medline] [Order article via Infotrieve]
31. Butz, S., Stappert, J., Weissig, H., and Kemler, R. (1992) Science 257, 1142-4[Medline] [Order article via Infotrieve]
32. Guan, K., and Dixon, J. E. (1991) Anal. Biochem. 192, 262-267[Medline] [Order article via Infotrieve]
33. Marrs, J. A., Napolitano, E. W., Murphy-Erdosh, C., Mays, R. W., Reichardt, L. F., and Nelson, W. J. (1993) J. Cell Biol. 123, 149-164[Abstract]
34. Nollet, F., Kools, P., and van Roy, F. (2000) J. Mol. Biol. 299, 551-72[CrossRef][Medline] [Order article via Infotrieve]
35. Rechsteiner, M., and Rogers, S. W. (1996) Trends Biochem. Sci. 21, 267-271[CrossRef][Medline] [Order article via Infotrieve]
36. Creighton, T. E. (1989) Protein Structure: A Practical Approach , IRL Press, Washington, D.C.
37. Greenfield, N., and Fasman, G. D. (1969) Biochemistry 8, 4108-4116[Medline] [Order article via Infotrieve]
38. Brahms, S., and Brahms, J. (1980) J. Mol. Biol. 138, 149-178[Medline] [Order article via Infotrieve]
39. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids , John Wiley & Sons, New York
40. Ozawa, M., and Kemler, R. (1992) J. Cell Biol. 116, 989-996[Abstract]
41. Ikai, A. (1980) J. Biochem. (Tokyo) 88, 1895-1898[Abstract]
42. Gilon, T., Chomsky, O., and Kulka, R. G. (1998) EMBO J. 17, 2759-2766[Abstract/Free Full Text]
43. Guruprasad, K., Reddy, B. V., and Pandit, M. W. (1990) Protein Eng. 4, 155-161[Abstract]
44. Conti, E., Uy, M., Leighton, L., Blobel, G., and Kuriyan, J. (1998) Cell 94, 193-204[Medline] [Order article via Infotrieve]
45. Hendsch, Z. S., and Tidor, B. (1994) Protein Sci. 3, 211-226[Abstract/Free Full Text]
46. Waldburger, C. D., Schildbach, J. F., and Sauer, R. T. (1995) Nat. Struct. Biol. 2, 122-128[Medline] [Order article via Infotrieve]
47. Pontius, B. W. (1993) Trends Biochem. Sci. 18, 181-186[CrossRef][Medline] [Order article via Infotrieve]
48. Shore, E. M., and Nelson, W. J. (1991) J. Biol. Chem. 266, 19672-19680[Abstract/Free Full Text]
49. Hericourt, F., Blanc, S., Redeker, V., and Jupin, I. (2000) Biochem. J. 349, 417-425[CrossRef][Medline] [Order article via Infotrieve]
50. Feng, Y., and Davis, N. G. (2000) Mol. Cell. Biol. 20, 5350-5359[Abstract/Free Full Text]
51. Yaglom, J., Linskens, M. H., Sadis, S., Rubin, D. M., Futcher, B., and Finley, D. (1995) Mol. Cell. Biol. 15, 731-741[Abstract]
52. Turnell, A. S., Grand, R. J., Gorbea, C., Zhang, X., Wang, W., Mymryk, J. S., and Gallimore, P. H. (2000) EMBO J. 19, 4759-4773[Abstract/Free Full Text]
53. Marchal, C., Haguenauer-Tsapis, R., and Urban-Grimal, D. (2000) J. Biol. Chem. 275, 23608-23614[Abstract/Free Full Text]
54. Wulczyn, F. G., Krappmann, D., and Scheidereit, C. (1996) J. Mol. Med. 74, 749-769[CrossRef][Medline] [Order article via Infotrieve]
55. Lin, R., Beauparlant, P., Makris, C., Meloche, S., and Hiscott, J. (1996) Mol. Cell. Biol. 16, 1401-1409[Abstract]
56. Schwarz, E. M., Van Antwerp, D., and Verma, I. M. (1996) Mol. Cell. Biol. 16, 3554-3559[Abstract]
57. Tran, K., Merika, M., and Thanos, D. (1997) Mol. Cell. Biol. 17, 5386-5399[Abstract]
58. Schoonbroodt, S., Ferreira, V., Best-Belpomme, M., Boelaert, J. R., Legrand-Poels, S., Korner, M., and Piette, J. (2000) J. Immunol. 164, 4292-4300[Abstract/Free Full Text]
59. Fenwick, C., Na, S. Y., Voll, R. E., Zhong, H., Im, S. Y., Lee, J. W., and Ghosh, S. (2000) Science 287, 869-873[Abstract/Free Full Text]
60. Bradley, R. S., Cowin, P., and Brown, A. M. C. (1993) J. Cell Biol. 123, 1857-1865[Abstract]
61. Hinck, L., Nelson, W. J., and Papkoff, J. (1994) J. Cell Biol. 124, 729-741[Abstract]
62. Nagafuchi, A., Takeichi, M., and Tsukita, S. (1991) Cell 65, 849-857[Medline] [Order article via Infotrieve]
63. Kowalczyk, A. P., Palka, H. L., Luu, H. H., Nilles, L. A., Anderson, J. E., Wheelock, M. J., and Green, K. J. (1994) J. Biol. Chem. 269, 31214-31223[Abstract/Free Full Text]
64. Guger, K. A., and Gumbiner, B. M. (1995) Dev. Biol. 172, 115-125[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.